Brian M. Stolz, EVP Administration & CHCO at Valeant Pharmaceuticals International, Inc. (VRX), bought 2,400 shares at $42.05 ($101K) on 2011-11-17, disclosed to the SEC on 2011-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRX | BUY | 2012-11-08 | $108K | — | Filing → |
| VRX | BUY | 2012-05-14 | $266K | — | Filing → |
| VRX | BUY | 2011-08-30 | $110K | — | Filing → |